BDK Advokati has contributed the Serbia chapter to the 2025 edition of the Chambers Life Sciences Global Practice Guide.
Authored by partner Bisera Andrijašević and associate Anja Gligorević, the chapter provides comprehensive overview of Serbia’s life sciences regulatory landscape.
The Law and Practice section covers key aspects of regulatory processes and requirements throughout the entire product life cycle, from clinical trials and manufacturing to marketing authorisations, distribution and advertising, to pricing and reimbursement. And while this section provides a snapshoot of the current regulatory landscape, in the Trends and Developments section we discuss the recent and anticipated legislative changes, efforts to streamline regulatory procedures, increased scrutiny by the Serbian Commission for Protection of Competition, and the ongoing digitalisation of the healthcare sector and the establishment of the Centre for the Fourth Industrial Revolution Serbia and the BIO4 Campus, all within the wider ambitions of Serbia to become a global biotechnology hub.
To access the entire guide online, use the following link: Life Sciences 2025.
Photo by Maxim Berg on Unsplash
